commit bf321f9bd09e8ca26476600ab0f29df16ef01085
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Thu Apr 1 11:20:48 2021 +0200

    APRIL 2021

diff --git a/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml b/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml
index 9d053b9..e09f2c9 100644
--- a/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml	
+++ b/Rare diseases and classifications/Cross-referencing of rare diseases/XML/en_product1.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2021-03-01 04:28:15" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2021-04-01 04:28:44" version="1.3.7 / 4.1.7 [2020-12-03] (orientdb version)" copyright="Orphanet (c) 2021" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="10524">
+  <DisorderList count="10537">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166024</ExpertLink>
@@ -3315,7 +3315,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Krabbe disease is a lysosomal disorder that affects the white matter of the central and peripheral nervous systems. It includes infantile, late-infantile/juvenile and adult forms.</Contents>
+              <Contents>A rare lysosomal disorder that affects the white matter of the central and peripheral nervous systems characterized by neurodegeneration with severity depending on the age of onset (infantile, late-infantile, juvenile, adolescent and adulthood).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -7996,9 +7996,7 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
-        <Synonym lang="en">DM1</Synonym>
-        <Synonym lang="en">MD1</Synonym>
+      <SynonymList count="2">
         <Synonym lang="en">Myotonic dystrophy type 1</Synonym>
         <Synonym lang="en">Steinert disease</Synonym>
       </SynonymList>
@@ -9067,7 +9065,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17567">
@@ -12136,8 +12141,7 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
-        <Synonym lang="en">Sickle cell disease</Synonym>
+      <SynonymList count="0">
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -14504,7 +14508,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare genetic multisystemic neurodevelopmental disorder characterized by a distinct facial appearance, cardiac anomalies (most frequently supravalvular aortic stenosis), cognitive and developmental abnormalities, and connective tissue abnormalities (such as joint laxity).</Contents>
+              <Contents>A rare genetic multisystemic neurodevelopmental disorder characterized by a distinct facial appearance, cardiac anomalies (most frequently supravalvular aortic stenosis), cognitive and developmental abnormalities, and connective tissue abnormalities (e.g., joint laxity). Facial dysmorphism is characterized by a broad forehead, bitemporal narrowing, periorbital fullness, stellate and/or lacy iris pattern, short upturned nose with bulbous tip, long philtrum, wide mouth, full lips and mild micrognathia.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -16784,7 +16788,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Leber's hereditary optic neuropathy (LHON) is a mitochondrial neurodegenerative disease affecting the optic nerve and often characterized by sudden vision loss in young adult carriers.</Contents>
+              <Contents>A rare hereditary optic neuropathy characterized by sudden onset, painless central vision loss, loss of retinal ganglion cells and optic atrophy.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -17461,7 +17465,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124126" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161939" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic epilepsy syndrome characterized by infantile or childhood onset of focal motor seizures remitting with age, as well as childhood onset of exercise-induced dystonia which often persists into adulthood. Additional reported features include nystagmus and postural tremor of the hands.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17532">
@@ -18779,9 +18793,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="105230">
+        <ExternalReference id="187790">
           <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
+          <Reference>C44.9</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -19450,6 +19464,19 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="7">
+        <ExternalReference id="187751">
+          <Source>ICD-10</Source>
+          <Reference>C97</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="105178">
           <Source>MeSH</Source>
           <Reference>D016864</Reference>
@@ -19516,19 +19543,6 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="105182">
-          <Source>ICD-10</Source>
-          <Reference>D48.9</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -21656,9 +21670,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="105302">
+        <ExternalReference id="187752">
           <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
+          <Reference>C64</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -23907,7 +23921,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
+        <Synonym lang="en">Dysencephalia splanchnocystica</Synonym>
         <Synonym lang="en">Meckel-Gruber syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21401">
@@ -28896,7 +28911,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease is described under  15q overgrowth syndrome</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17811">
@@ -29194,9 +29216,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="120616">
+        <ExternalReference id="188400">
           <Source>ICD-10</Source>
-          <Reference>D81.2</Reference>
+          <Reference>D89.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -34437,7 +34459,11 @@
       <OrphaCode>1046</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=1046</ExpertLink>
       <Name lang="en">Lethal hemolytic anemia-genital anomalies syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="460">
+          <Value>512</Value>
+          <Label>Historical entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -43626,7 +43652,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterised by the association of a mitochondrial encephalomyopathy and an aminoacidopathy. It has been described in two brothers presenting with developmental delay, neurological signs, deafness, exercise intolerance, lactic acidosis and elevation of several plasmatic amino acids. Mitochondria morphology was found to be abnormal on muscle biopsy. Transmission is likely to be linked to maternal mitochondrial DNA.</Contents>
+              <Contents>A rare mitochondrial DNA depletion syndrome characterized by neonatal or infantile onset of global developmental delay, hypotonia, failure to thrive, progressive neurologic decline, sensorineural deafness, and movement disorder. Seizures, external ophthalmoplegia, polyneuropathy, cardiomyopathy, and renal tubular dysfunction have also been reported. Brain imaging may show T2-weighted hyperintensities in the basal ganglia, and laboratory examination may reveal lactic acidosis and mild methylmalonic aciduria.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -49623,8 +49649,7 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="2">
-        <Synonym lang="en">Congenital facial diplegia</Synonym>
+      <SynonymList count="1">
         <Synonym lang="en">Möbius syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -54970,7 +54995,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare fetopathy characterized by ocular, visceral or intracranial lesions secondary to maternal primo-infection by &lt;i&gt;Toxoplasma gondii&lt;/i&gt; (Tg).</Contents>
+              <Contents>A rare fetopathy characterized by ocular, visceral or intracranial lesions secondary to maternal primary infection by &lt;i&gt;Toxoplasma gondii&lt;/i&gt; (Tg).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -55669,7 +55694,7 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="23">
+      <ExternalReferenceList count="27">
         <ExternalReference id="184343">
           <Source>OMIM</Source>
           <Reference>617796</Reference>
@@ -55692,6 +55717,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187927">
+          <Source>ICD-10</Source>
+          <Reference>F71</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="41038">
           <Source>OMIM</Source>
           <Reference>156200</Reference>
@@ -55868,6 +55906,32 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187928">
+          <Source>ICD-10</Source>
+          <Reference>F72</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187929">
+          <Source>ICD-10</Source>
+          <Reference>F73</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="147659">
           <Source>OMIM</Source>
           <Reference>616977</Reference>
@@ -55923,6 +55987,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187926">
+          <Source>ICD-10</Source>
+          <Reference>F70</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -57957,7 +58034,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A subacute fatal neurodegenerative disease belonging to the group of prion diseases, characterized by a clinical triad of dementia, myoclonus, and EEG anomalies, along with neuropathological evidence of neuronal loss, spongiform changes, and astrocytosis. There are three types of CJD: sporadicCJD (sCJD), inherited CJD , and iatrogenic and variant CJD (vCJD).</Contents>
+              <Contents>A rare sporadic human prion disease characterized by rapidly progressive cognitive impairment in combination with variable neurologic signs and symptoms including myoclonus, visual or cerebellar problems, pyramidal or extrapyramidal features, or akinetic mutism. Brain imaging may show high signal intensity in caudate, putamen, and/or cortical regions, and a typical EEG pattern consisting of generalized periodic sharp wave complexes is observed in many cases. The disease is invariably fatal within less than two years. Neuropathologic examination reveals deposition of abnormal prion protein in brain tissue, as well as spongiform change and massive neuronal loss and gliosis.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -61152,7 +61229,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset progressive myopathy characterized by progressive eyelid ptosis, dysphagia, dysarthria and proximal limb weakness.</Contents>
+              <Contents>A rare, adult-onset, progressive myopathy characterized by progressive eyelid ptosis, ophthalmoplegia, dysphagia, dysarthria and proximal limb weakness.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -68120,7 +68197,20 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
+      <ExternalReferenceList count="4">
+        <ExternalReference id="187908">
+          <Source>ICD-10</Source>
+          <Reference>P91.2</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="120687">
           <Source>MeSH</Source>
           <Reference>D007969</Reference>
@@ -73453,7 +73543,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>SeSAME syndrome is characterized by seizures, sensorineural deafness, ataxia, intellectual deficit, and electrolyte imbalance (hypokalemia, metabolic alkalosis, and hypomagnesemia).</Contents>
+              <Contents>A rare genetic disease characterized by the association of epilepsy, ataxia, sensorineural hearing impairment, and renal tubulopathy. Patients present in infancy with generalized seizures, cerebellar dysfunction (including gait ataxia, intention tremor, and dysdiadochokinesis), and variable developmental delay and sensorineural hearing loss. Laboratory studies show persistent hypokalemic metabolic acidosis with hypomagnesemia. Additional reported neurologic features include brisk deep tendon reflexes, ankle clonus, extensor plantar responses, or nystagmus.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -74826,7 +74916,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Fatal familial insomnia (FFI) is a very rare form of prion disease (see this term) characterized by subacute onset of insomnia showing as a reduced overall sleep time, autonomic dysfunction, and motor disturbances.</Contents>
+              <Contents>A rare inherited human prion disease characterized by adult onset of progressive disturbance and loss of circadian rhythms, dysautonomia with increased sympathetic activity, and cognitive impairment with fluctuating vigilance, impaired long-term memory, disorientation, and oneiric states. Motor disturbances include myoclonus, cerebellar ataxia, and pyramidal signs. The disease rapidly leads to a somnolent or comatose state and is typically fatal after 9 or 30 months on average (bimodal course). Neuropathologic examination shows marked neuronal loss and gliosis predominantly in thalamic nuclei and inferior olives, while deposition of abnormal prion protein may be relatively sparse.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -89490,13 +89580,13 @@
       <SynonymList count="1">
         <Synonym lang="en">ATR-X syndrome</Synonym>
       </SynonymList>
-      <DisorderType id="21394">
-        <Name lang="en">Disease</Name>
+      <DisorderType id="21401">
+        <Name lang="en">Malformation syndrome</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
+      <ExternalReferenceList count="4">
         <ExternalReference id="107509">
           <Source>UMLS</Source>
           <Reference>C1845055</Reference>
@@ -89532,8 +89622,79 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="188010">
+          <Source>OMIM</Source>
+          <Reference>309580</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation/>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="6">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900" cycle="true"/>
+          <RootDisorder id="11034">
+            <OrphaCode>73220</OrphaCode>
+            <Name lang="en">X-linked intellectual disability-hypotonic face syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900" cycle="true"/>
+          <RootDisorder id="12528">
+            <OrphaCode>93970</OrphaCode>
+            <Name lang="en">Holmes-Gang syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900" cycle="true"/>
+          <RootDisorder id="12529">
+            <OrphaCode>93971</OrphaCode>
+            <Name lang="en">Chudley-Lowry-Hoar syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900" cycle="true"/>
+          <RootDisorder id="12531">
+            <OrphaCode>93973</OrphaCode>
+            <Name lang="en">Carpenter-Waziri syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900" cycle="true"/>
+          <RootDisorder id="12532">
+            <OrphaCode>93974</OrphaCode>
+            <Name lang="en">Smith-Fineman-Myers syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900" cycle="true"/>
+          <RootDisorder id="20048">
+            <OrphaCode>263355</OrphaCode>
+            <Name lang="en">OBSOLETE: ATR-X-related syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="3566" lang="en">
@@ -105528,7 +105689,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124135" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161949" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare congenital non-syndromic heart malformation characterized by a bulging of the left ventricular wall, connected to the left ventricle by a wide neck (with a ratio of the connection to the body of the anomaly &gt;1). The dimensions of described aneurysms range from 0.5 cm in diameter up to a size of 8x9 cm. Most frequent locations are the left ventricular apex and the perivalvular area. Aneurysms can be a- or dyskinetic or show almost normal contractility. Patients may remain asymptomatic or present with systemic embolization, congestive heart failure, valvular regurgitation, ventricular wall rupture, ventricular tachycardia, or sudden cardiac death.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="16775">
@@ -108949,7 +109120,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare autosomal recessive acromesomelic dysplasia characterized by severe dwarfism (adult height &gt;120 cm), both axial and appendicular involvement (shortening of the middle and distal segments of limbs and vertebral shortening), and with normal facial appearance and intelligence. It is a less severe form than acromesomelic dysplasia, Grebe type and acromesomelic dysplasia, Hunter-Thomson type .</Contents>
+              <Contents>A rare autosomal recessive acromesomelic dysplasia characterized by severe dwarfism (adult height &lt;120 cm), both axial and appendicular involvement (shortening of the middle and distal segments of limbs and vertebral shortening), and with normal facial appearance and intelligence. It is a less severe form than acromesomelic dysplasia, Grebe type and acromesomelic dysplasia, Hunter-Thomson type .</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -110215,8 +110386,7 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
-        <Synonym lang="en">ATM/TM</Synonym>
+      <SynonymList count="0">
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -115075,7 +115245,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Branchio-oculo-facial syndrome (BOFS) is characterised by low birth weight and growth retardation, bilateral branchial clefts that may be hemangiomatous, sometimes with linear skin lesions behind the ears ('burn-like' lesions), congenital strabismus, obstructed nasolacrimal ducts, a broad nasal bridge with a flattened nasal tip, a protruding upper lip with an unusually broad and prominent philtrum, and full mouth.</Contents>
+              <Contents>A rare, dominantly inherited multiple congenital anomalies syndrome characterized by highly variable clinical phenotype involving the three main affected systems: branchial (cutaneous) defects, ophthalmic malformations and facial anomalies. Additional features can be present.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -120502,9 +120672,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="3">
-        <ExternalReference id="119953">
+        <ExternalReference id="187919">
           <Source>ICD-10</Source>
-          <Reference>E75.2</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -122340,7 +122510,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17071">
@@ -123660,7 +123837,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1659">
@@ -123802,7 +123986,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17080">
@@ -126099,7 +126290,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124111" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161803" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare otorhinolaryngological malformation characterized by congenital, typically bilateral and paramedian, symmetric or asymmetric fistulae in the lower lip, which are lined by labial mucosa. The malformation is usually asymptomatic, although it may communicate with accessory salivary glands and then result in secretion of saliva from the opening. Infections may also occur.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1603">
@@ -128655,7 +128856,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1569">
@@ -132146,7 +132354,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17118">
@@ -132249,7 +132464,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1567">
@@ -132494,7 +132716,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17112">
@@ -134730,7 +134959,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A very rare acrofacialdysostosis characterized by mild intrauterine growth retardation (IUGR), postnatal short stature, microcephaly, widow's peak, mandibulofacial dysostosis without cleft palate, frequent caries, mild pre- and postaxial limb hypoplasia with brachydactyly, mild interdigital webbing, simian creases, inguinal hernia and cryptorchidism and hypospadias in males.</Contents>
+              <Contents>A rare congenital acrofacial dysostosis characterized by mild intrauterine growth retardation, postnatal short stature, microcephaly, intellectual disability, moderate mandibulofacial dysostosis (including dental anomalies and/or malpositioning, microretrognathia, and malar hypoplasia), and mild pre- and postaxial limb hypoplasia with generalized brachydactyly, mild interdigital webbing, single transverse palmar creases and clinodactyly. Reported facial features include high forehead, widow's peak, downslanted palpebral fissures, sparse lateral eyebrows, and small or dysplastic ears. Variably associated features include frequent caries, preauricular fistulae, inguinal hernia, spina bifida occulta, and cryptorchidism and hypospadias in males.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -153446,11 +153675,11 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="109432">
+        <ExternalReference id="187791">
           <Source>ICD-10</Source>
           <Reference>Q87.0</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21597">
             <Name lang="en">Index term (The ORPHA code is listed in the ICD10 Index)</Name>
@@ -157560,7 +157789,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Femur-fibula-ulna (FFU) complex is a non-lethal congenital anomaly of unknown etiology, more frequently reported in males than females, characterized by a highly variable combination of defects of the femur, fibula, and/or ulna, with striking asymmetry, including absence of the proximal part of the femur, absence of the fibula and malformation of the ulnar side of the upper limb. Axial skeleton, internal organs and intellectual function are usually normal.</Contents>
+              <Contents>A rare congenital limb malformation syndrome characterized by a highly variable combination of congenital anomalies of the femur, fibula, and/or ulna, which can appear along with finger/toe anomalies at the ulnar/fibular side. Limb defects are asymmetrical, with upper limbs more often affected than lower limbs, and the right side of the body more often affected than the left. Abnormalities of the upper limb include amelia, hypoplasia of the humerus, humero-radial synostosis, and malformation of the ulna and ulnar rays. Abnormalities of the lower limb include absence of the proximal part of the femur and absence of the fibula. Axial skeleton, internal organs and intellectual function are usually normal.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -161107,7 +161336,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Lacrimoauriculodentodigital (LADD) syndrome is a multiple congenital anomaly syndrome characterized by hypoplasia, aplasia or atresia of the lacrimal system; anomalies of the ears and hearing loss; hypoplasias, apalsias or atresias of the salivary glands; dental anomalies and digital malformations.</Contents>
+              <Contents>A rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by hypoplasia, aplasia or atresia of the lacrimal system, anomalies of the ears with sensorineural or mixed hearing loss, hypoplasia, aplasia or atresia of the salivary glands, dental anomalies, and digital malformations. Patients present obstruction of the nasal lacrimal ducts that can lead to epiphora, and chronic conjunctivitis due to alacrimia. Aplasia or hypoplasia of the salivary glands lead to dry mouth and early onset of severe dental caries. Dental features include late tooth eruption, small and peg-shaped lateral maxillary incisors and mild enamel dysplasia. The digital features are variable and include fifth finger clinodactyly, duplication of the distal phalanx of the thumb, triphalangeal thumb, and/or syndactyly. Unilateral radial aplasia and radial-ulnar synostosis have also been reported in association.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -180649,7 +180878,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic, hemoglobinopathy characterized by generally mild clinical phenotype, high fetal hemoglobin levels and mild microcytosis and hypochromia. In some cases, acute sickle cell disease manifestations were reported, namely acute chest syndrome and acute pain crisis.</Contents>
+              <Contents>A rare, genetic, hemoglobinopathy characterized by generally mild clinical phenotype, high fetal hemoglobin levels and mild microcytosis and hypochromia. In some cases, acute sickle cell disease manifestations were reported, namely acute chest syndrome and acute pain crisis. The genotype is characterized by the combination of an HbS and HbF allele; symptoms depend on the degree of HbF:HbS expressivity with patients with more than 35% pancellular HbF expression being asymptomatic. Symptomatic patients have heterocellular expression of HbF.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -180912,7 +181141,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic hemoglobinopathy characterized by anemia and erythrocyte abnormalities including anisocytosis, poikilocytosis, target cells, and irreversibly sickled cells. Clinical course is similar to sickle cell disease, including acute episodes of pain, splenic infarction and splenic sequestration crisis, vaso-occlusive crisis, acute chest syndrome, ischemic brain injury, osteomyelitis and avascular bone necrosis.</Contents>
+              <Contents>A rare, genetic hemoglobinopathy characterized by all the characteristics of sickle cell anemia (SCA). Clinical course is similar to SCA, including acute episodes of pain, splenic infarction and splenic sequestration crisis, vaso-occlusive crisis, acute chest syndrome, ischemic brain injury, osteomyelitis and avascular bone necrosis. The genotype is characterized by an HbS allele in combination with the HbD variant, beta121Glu&gt;Gln.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -180972,7 +181201,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic hemoglobinopathy usually characterized by mild hemolysis without vaso-occlusive complications or abnormality of red blood cell morphology. However, more severe manifestations have also been reported, including hematuria, splenic infarction, acute chest syndrome, acute episodes of pain and reversible bone marrow necrosis.</Contents>
+              <Contents>A rare, genetic hemoglobinopathy usually characterized by mild microcytic hemolysis and, very rarely, vaso-occlusive complications. Severe manifestations have been reported, including hematuria, splenic infarction, acute chest syndrome, acute episodes of pain and reversible bone marrow necrosis. The genotype is characterized by an HbS allele in combination with an HbE variant (beta26glu&gt;lys); symptoms are due to the low allelic expression of HbE leading to HbS predominance (65+/-5%).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -186656,17 +186885,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="4">
-        <ExternalReference id="179647">
+        <ExternalReference id="188401">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="51676">
@@ -191956,9 +192185,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="122109">
+        <ExternalReference id="187910">
           <Source>ICD-10</Source>
-          <Reference>G11.4</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -208578,7 +208807,11 @@
       <OrphaCode>3056</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=3056</ExpertLink>
       <Name lang="en">X-linked intellectual disability, Brooks type</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -208592,44 +208825,27 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="2">
-        <ExternalReference id="178932">
-          <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="14539">
-          <Source>OMIM</Source>
-          <Reference>300612</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491">
+            <OrphaCode>528084</OrphaCode>
+            <Name lang="en">Non-specific syndromic intellectual disability</Name>
+          </TargetDisorder>
+          <RootDisorder id="2746" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="96965" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="118760" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>X-linked intellectual disability, Brooks type is a rare X-linked intellectual disability syndrome characterized by failure to thrive, speech delay, intellectual disability, muscle hypotonia, spastic diplegia, optic atrophy with myopia, and distinct facial features (including triangular face, bifrontal narrowness, deeply set eyes, low-set/cupped ears, prominent nose, short philtrum, and thin upper lip with tented morphology) that can be evident from birth. Additional manifestations reported in some patients include large joint contractures and pectus excavatum (which become more evident with age) and seizures.</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Non-specific syndromic intellectual disability</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -212414,11 +212630,11 @@
     <Disorder id="20048">
       <OrphaCode>263355</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=263355</ExpertLink>
-      <Name lang="en">ATR-X-related syndrome</Name>
+      <Name lang="en">OBSOLETE: ATR-X-related syndrome</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="0">
@@ -212431,7 +212647,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900">
+            <OrphaCode>847</OrphaCode>
+            <Name lang="en">Alpha-thalassemia-X-linked intellectual disability syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="20048" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="-1" lang="en">
@@ -240827,12 +241053,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="124284" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="162251" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare familial partial lipodystrophy characterized by severe partial lipoatrophy affecting the limbs, trunk, and abdomen, together with faciocervical fat accumulation. Additional manifestations include diabetes, acanthosis nigricans, liver steatosis, and hypertriglyceridemia, as well as low serum leptin and adiponectin levels. Severe cardiac rhythm and conduction disturbances have also been reported.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This disease is described under  Familial partial lipodystrophy</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -242268,7 +242497,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Deafness-enamel hypoplasia-nail defects syndrome is characterised by sensorineural hearing loss, generalised enamel hypoplasia of the permanent dentition with normal primary dentition, and nail defects (Beau's lines and leukonychia). Less than 10 patients have been described so far. Transmission is autosomal recessive.</Contents>
+              <Contents>A rare genetic disease characterized by sensorineural hearing loss, abnormalities in the secondary dentition (such as enamel hypoplasia, taurodontism, or dental overcrowding), and nail abnormalities (including leukonychia and presence of transverse ridges). Association with macular dystrophy has also been reported.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -242727,7 +242956,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="123945" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161563" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by pre- and postnatal growth restriction, microcephaly, mild to severe intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphism (with small and elongated face, bifrontal narrowing, epicanthus, short nose, small nares, dysplastic ears, and short neck). Additional variable features include limb malformations, cardiac anomalies, abnormal skin pigmentation, and recurrent infections, among others.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2872">
@@ -254130,7 +254369,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Overlap myositis (OM) is a form of idiopathic inflammatory myopathy (IIM) characterized by myositis with at least one clinical and/or autoantibody overlap feature.</Contents>
+              <Contents>A rare idiopathic inflammatory myopathy (IIM) with a heterogeneous phenotype characterized by myositis with at least one clinical and/or autoantibody overlap feature. Possible clinical overlap features include polyarthritis, Raynaud's phenomenon, sclerodactyly, scleroderma (proximal to metacarpophalangeal joints), lung interstitial pneumonia, and/or clinical signs of systemic lupus erythematosus (SLE).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -256433,7 +256672,7 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="41">
+      <ExternalReferenceList count="45">
         <ExternalReference id="126705">
           <Source>OMIM</Source>
           <Reference>300983</Reference>
@@ -256852,6 +257091,58 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187937">
+          <Source>ICD-10</Source>
+          <Reference>F73</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187934">
+          <Source>ICD-10</Source>
+          <Reference>F70</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187935">
+          <Source>ICD-10</Source>
+          <Reference>F71</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187936">
+          <Source>ICD-10</Source>
+          <Reference>F72</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="126737">
           <Source>OMIM</Source>
           <Reference>300984</Reference>
@@ -262033,7 +262324,11 @@
       <OrphaCode>1101</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=1101</ExpertLink>
       <Name lang="en">Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="460">
+          <Value>512</Value>
+          <Label>Historical entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -262778,7 +263073,7 @@
     <Disorder id="3183">
       <OrphaCode>3051</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=3051</ExpertLink>
-      <Name lang="en">Intellectual disability-sparse hair-brachydactyly syndrome</Name>
+      <Name lang="en">Nicolaides-Baraitser syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -262786,7 +263081,7 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
-        <Synonym lang="en">Nicolaides-Baraitser syndrome</Synonym>
+        <Synonym lang="en">Intellectual disability-sparse hair-brachydactyly syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21401">
         <Name lang="en">Malformation syndrome</Name>
@@ -262827,7 +263122,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Intellectual disability-sparse hair-brachydactyly syndrome is a very rare condition of unknown etiology consisting of short stature, hypotrichosis, brachydactyly with cone-shaped epiphyses, epilepsy and severe mental delay. After the initial delineation of this syndrome by Nicolaides and Baraitser in 1993, only five more patients were published in the literature up to now.</Contents>
+              <Contents>A rare, genetic, syndromic intellectual disability characterized by short stature, sparse hair, characteristic coarse face, brachydactyly with prominent interphalangeal joints, seizures and intellectual disability. Facial characteristics include triangular shaped face, dense and prominent eyelashes, rounded premaxilla, broad nasal base, thick alae nasi, upturned nasal tip, broad philtrum, thin upper vermilion, thick and everted lower vermilion and wide mouth.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -266525,7 +266820,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic language disorder characterized by the core phenotype of childhood apraxia of speech (CAS) while also further aspects such as receptive and expressive language impairment or oral motor dyspraxia often occur.</Contents>
+              <Contents>A rare neurologic disease characterized by impaired ability to execute complex coordinated movements underlying the production of speech, leading to highly unintelligible speech in the absence of muscular or sensory deficits. Initial presentation may be a severe expressive speech delay. Later, characteristic features are inconsistent errors on consonants and vowels in repeated productions of syllables or words, lengthened and disrupted coarticulatory transitions between sounds and syllables, and inappropriate prosody.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -275174,14 +275469,15 @@
     <Disorder id="3460">
       <OrphaCode>3189</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=3189</ExpertLink>
-      <Name lang="en">Congenital pulmonary valve stenosis</Name>
+      <Name lang="en">Congenital pulmonary valvar stenosis</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Congenital stenosis of pulmonary valve</Synonym>
       </SynonymList>
       <DisorderType id="21415">
         <Name lang="en">Morphological anomaly</Name>
@@ -284881,9 +285177,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="121469">
+        <ExternalReference id="187909">
           <Source>ICD-10</Source>
-          <Reference>K72.0</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -293871,17 +294167,7 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="104171" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="126741" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>Pitt-Hopkins-like syndrome is a rare, genetic, syndromic intellectual disability disorder characterized by severe intellectual disability, lack of speech with normal, or mildly delayed, motor development, episodic breathing abnormalities, early-onset seizures and facial dysmorphism which only includes a wide mouth. Abnormal sleep-wake cycles, autistic behavior and stereotypic movements are commonly associated.</Contents>
-            </TextSection>
-          </TextSectionList>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="19062">
@@ -305807,7 +306093,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare renal or urinary tract malformation characterized by ectatic precalyceal papillary collecting ducts, typically involving all renal papillae of both kidneys, and associated with impaired proximal and distal tubular function. Patients may be asymptomatic or present in young adulthood with recurrent stone formation, nephrocalcinosis, micro- and macrohematuria, recurrent urinary tract infection and pyelonephritis, hypercalciuria and hypocitraturia, and reduction in bone mineral density.</Contents>
+              <Contents>A rare renal tract malformation characterized by dilated malformation of the medullary collecting ducts (typically bilateral), and associated with stone formation, renal colic, hematuria, urinary tract infection, nephrocalcinosis, calcium nephrolithiasis, pyelonephritis, hypercalciuria and hypocitraturia. The disease is associated with abnormal distal tubular functions.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -309989,7 +310275,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Late-onset localized jonctional epidermolysis bullosa-intellectual disability syndrome is a rare junctional epidermolysis bullosa subtype characterized by late-onset blistering surrounded by erythema and localized on the anterior aspect of the lower legs, associated with dystrophic toenails, tooth enamel defects and mild to severe intellectual disability. Lens subluxation and mild facial dysmorphism (with short midface, prognatism and thin upper lip vermilion) are additional reported features. There have been no further descriptions in the literature since 1992.</Contents>
+              <Contents>A rare junctional epidermolysis bullosa subtype characterized by late-onset blistering surrounded by erythema and localized on the anterior aspect of the lower legs, associated with dystrophic toenails, tooth enamel defects and mild to severe intellectual disability. Lens subluxation and mild facial dysmorphism (with short midface, prognatism and thin upper lip vermilion) are additional reported features. There have been no further descriptions in the literature since 1992.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -313747,7 +314033,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare disorder of sexual maturation characterized by gonadotropin (Gn) deficiency with low sex steroid levels associated with low levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH).</Contents>
+              <Contents>A rare, genetic pituitary hormone deficiency characterized by gonadotropin (Gn) deficiency with low sex steroid levels associated with low levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH). This disorder may be associated with a normal (normosmic) or impaired sense of smell (Kallmann syndrome).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -315182,6 +315468,19 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="3">
+        <ExternalReference id="188407">
+          <Source>ICD-10</Source>
+          <Reference>L57.1</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="138901">
           <Source>UMLS</Source>
           <Reference>C1510437</Reference>
@@ -315204,19 +315503,6 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="123819">
-          <Source>ICD-10</Source>
-          <Reference>L57.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -316571,19 +316857,6 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="123801">
-          <Source>ICD-10</Source>
-          <Reference>N00.5</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
         <ExternalReference id="78613">
           <Source>OMIM</Source>
           <Reference>614809</Reference>
@@ -316595,6 +316868,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187904">
+          <Source>ICD-10</Source>
+          <Reference>N03.5</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="1">
         <DisorderDisorderAssociation>
@@ -316852,9 +317138,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="123800">
+        <ExternalReference id="187903">
           <Source>ICD-10</Source>
-          <Reference>N00.5</Reference>
+          <Reference>N03.5</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -316933,9 +317219,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="123799">
+        <ExternalReference id="187906">
           <Source>ICD-10</Source>
-          <Reference>N00.5</Reference>
+          <Reference>N03.5</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -317111,7 +317397,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="123784">
+        <ExternalReference id="188406">
           <Source>ICD-10</Source>
           <Reference>Q87.2</Reference>
           <DisorderMappingRelation id="21534">
@@ -317120,8 +317406,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -321292,17 +321578,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="123740">
+        <ExternalReference id="188405">
           <Source>ICD-10</Source>
-          <Reference>Q35.9</Reference>
+          <Reference>Q38.6</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -324031,9 +324317,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="158866">
+        <ExternalReference id="187915">
           <Source>ICD-10</Source>
-          <Reference>I42.2</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -324091,9 +324377,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="123672">
+        <ExternalReference id="187913">
           <Source>ICD-10</Source>
-          <Reference>G71.3</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -335868,17 +336154,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="123959">
+        <ExternalReference id="188411">
           <Source>ICD-10</Source>
-          <Reference>Q93.5</Reference>
+          <Reference>Q87.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="85817">
@@ -336099,6 +336385,19 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
+        <ExternalReference id="188410">
+          <Source>ICD-10</Source>
+          <Reference>C93.3</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="81854">
           <Source>OMIM</Source>
           <Reference>613563</Reference>
@@ -336110,19 +336409,6 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="123955">
-          <Source>ICD-10</Source>
-          <Reference>Q87.1</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -336285,7 +336571,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="123952">
+        <ExternalReference id="188409">
           <Source>ICD-10</Source>
           <Reference>H51.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -336294,8 +336580,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -336772,9 +337058,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="123944">
+        <ExternalReference id="187917">
           <Source>ICD-10</Source>
-          <Reference>N15.8</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -341804,7 +342090,7 @@
     <Disorder id="22081">
       <OrphaCode>352577</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=352577</ExpertLink>
-      <Name lang="en">Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome</Name>
+      <Name lang="en">Bainbridge-Ropers syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -341812,7 +342098,7 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
-        <Synonym lang="en">Bainbridge-Ropers syndrome</Synonym>
+        <Synonym lang="en">Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -341855,7 +342141,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome is rare, genetic, syndromic intellectual disability disorder with a variable phenotypic presentation typically characterized by microcephaly, severe feeding difficulties, failure to thrive, severe global development delay that frequently results in absent/poor speech, moderate to profound intellectual disability, hypotonia and a distinctive facies that includes prominent forehead, high-arched, thin eyebrows, hypertelorism, downslanting palpebral fissures, long, tubular nose with broad tip and prominent nasal bridge and wide mouth with full, everted lower lip.</Contents>
+              <Contents>A rare, genetic, syndromic intellectual disability disorder with a variable phenotypic presentation typically characterized by microcephaly, severe feeding difficulties, failure to thrive, severe global development delay that frequently results in absent/poor speech, moderate to severe intellectual disability and hypotonia. Distinctive craniofacial features include prominent forehead, high-arched, thin eyebrows, hypertelorism, downslanting palpebral fissures, long, tubular nose with broad tip and prominent nasal bridge and wide mouth with full, everted lower lip. Joint laxity and ulnar deviation of wrists are also frequently observed.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -343492,17 +343778,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="123878">
+        <ExternalReference id="188408">
           <Source>ICD-10</Source>
-          <Reference>Q14.8</Reference>
+          <Reference>Q14.1</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -343866,7 +344152,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Roifman syndrome is a rare, genetic immuno-osseous dysplasia disorder characterized by pre- and post-natal growth retardation, hypotonia, borderline to moderate intellectual disability, retinal dystrophy, spondyloepiphyseal dysplasia (epiphyseal dysplasia, epiphyses ossification delay, vertebral changes) and skeletal anomalies (brachydactyly, fifth finger clinodactyly), as well as humeral immunodeficiency characterized by inability to generate specific antibodies and low circulating B-cells. Craniofacial dysmorphism, that typically inlcudes microcephaly, hypertelorism, long palpebral fissures, prominent eyelashes, a narrow, tubular, upturned nose with hypoplastic alae nasi, long philtrum and thin upper lip, are also associated.</Contents>
+              <Contents>A rare, genetic immuno-osseous dysplasia associated with pre- and post-natal growth retardation, retinopathy, microcephaly, intellectual disability and dysmorphic features.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -345568,7 +345854,11 @@
       <OrphaCode>294049</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=294049</ExpertLink>
       <Name lang="en">Reunion Island Larsen-like syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -345585,18 +345875,25 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11083">
+            <OrphaCode>75496</OrphaCode>
+            <Name lang="en">B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="20904" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="108468" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="136874" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>A rare, genetic, congenital disorder of glycosylation characterized by severe, pre- and post-natal short stature, joint hyperlaxity with multiple dislocations (elbows, fingers, hips, knees), and facial dysmorphism (round flat face, high forehead, hypertelorism, prominent bulging eyes with under-eye shadows, hypoplastic midface, microstomia, protruding lips). Other associated features may include cutaneous hyperextensibility, learning difficulties, and ocular abnormalities. Advanced carpal ossification, widened metaphyses, and, occasionally, radioulnar synostosis, scoliosis and a Swedish key appearance of the proximal femora, is observed on imaging.</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -358492,14 +358789,14 @@
         <Name lang="en">Group of disorders</Name>
       </DisorderGroup>
       <ExternalReferenceList count="3">
-        <ExternalReference id="172035">
+        <ExternalReference id="187907">
           <Source>ICD-10</Source>
-          <Reference>Q82.8</Reference>
+          <Reference>Q80.1</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
           </DisorderMappingICDRelation>
           <DisorderMappingValidationStatus id="21611">
             <Name lang="en">Validated</Name>
@@ -364486,20 +364783,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="3">
-        <ExternalReference id="74818">
-          <Source>OMIM</Source>
-          <Reference>611390</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="123548">
+        <ExternalReference id="187911">
           <Source>ICD-10</Source>
-          <Reference>G11.4</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -364510,6 +364796,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="74818">
+          <Source>OMIM</Source>
+          <Reference>611390</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation/>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="139588">
           <Source>UMLS</Source>
           <Reference>C1969645</Reference>
@@ -365980,20 +366277,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="74874">
-          <Source>OMIM</Source>
-          <Reference>614924</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="158857">
+        <ExternalReference id="187918">
           <Source>ICD-10</Source>
-          <Reference>G31.8</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -366004,6 +366290,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="74874">
+          <Source>OMIM</Source>
+          <Reference>614924</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation/>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -366074,7 +366371,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21264">
@@ -366124,7 +366428,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21270">
@@ -372689,7 +373000,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic, central nervous system malformation characterized by generalized or focal polmicrogryia-like cortical dysplasia and simplified gyral pattern, or alternatively by microlissencephaly and agenesis of the corpus callosum. Clinical manifestations are variable and include microcephaly, seizures, hypotonia, developmental delay, severe psychomotor delay, ataxia, spastic diplegia or tetraplegia, and ocular abnormalities (strabismus, ptosis or optic atrophy).</Contents>
+              <Contents>A rare, genetic, complex cerebral cortical malformation characterized by generalized or focal dysgyria (also named polymicrogryia-like cortical dysplasia) or alternatively by microlissencephaly with dysmorphic basal ganglia and dysgenesis of the corpus callosum. Clinical manifestations are variable and include microcephaly, seizures, hypotonia, developmental delay, severe psychomotor delay, ataxia, spastic diplegia or tetraplegia, and ocular abnormalities (strabismus, ptosis or optic atrophy).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -374869,7 +375180,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>PTEN hamartoma tumor syndrome (PHTS) is a term defining a group of clinically heterogeneous disorders united by a germline &lt;i&gt;PTEN&lt;/i&gt; mutation and the involvement of derivatives of all 3 germ cell layers, manifesting with hamartomas, overgrowth and neoplasia. Currently, subsets carrying clinical diagnoses of Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus and Proteus-like syndromes and SOLAMEN syndrome (see these terms) belong to PHTS.</Contents>
+              <Contents>A group rare skin tumor or hamartoma diseases characterized by a germline PTEN mutation and clinical manifestations of hamartomas, overgrowth, and increased risk of neoplasia, notably breast carcinomas, epithelial thyroid carcinomas, endometrial carcinomas, renal cell carcinomas, and colorectal carcinoma. Non-malignant manifestations include macrocephaly, benign thyroid pathology (especially Hashimoto thyroiditis), mucocutaneous hamartomas, colonic polyps, and vascular malformations. Diseases in this group include Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus-like syndrome, Lhermitte-Duclos disease, and Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -384632,17 +384943,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179655">
+        <ExternalReference id="188522">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>G60.2</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -386265,17 +386576,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179654">
+        <ExternalReference id="188521">
           <Source>ICD-10</Source>
-          <Reference>G40.4</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -386699,7 +387010,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare genetic multiple congenital anomalies syndrome characterized by global developmental delay and intellectual disability with limited or absent speech development, microcephaly, cardiac anomalies, and dysmorphic facial features, predominantly broad nasal tip and thin, tented upper lip. Variable genitourinary, gastrointestinal, musculoskeletal and/or ocular anomalies have also been reported.</Contents>
+              <Contents>A rare genetic neurodevelopmental disorder characterized by global developmental delay (DD) and variable degrees of intellectual disability (ID) with delayed or limited/absent speech development associated with neonatal hypotonia, feeding difficulties, cardiac anomalies and dysmorphic facial features, predominantly broad nasal tip and thin, tented upper lip. Microcephaly, frequent infections, gastrointestinal and/or ocular anomalies have also been described.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -388437,17 +388748,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179656">
+        <ExternalReference id="188523">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>Q87.0</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -388883,17 +389194,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179658">
+        <ExternalReference id="188525">
           <Source>ICD-10</Source>
-          <Reference>E75.2</Reference>
+          <Reference>G93.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="134963">
@@ -389076,7 +389387,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179657">
+        <ExternalReference id="188524">
           <Source>ICD-10</Source>
           <Reference>G11.0</Reference>
           <DisorderMappingRelation id="21534">
@@ -389085,8 +389396,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="134986">
@@ -389839,7 +390150,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Microcephalic primordial dwarfism due to RTTN deficiency is a rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by primary microcephaly, profound short stature, moderate to severe intellectual disability, global developmental delay, craniofacial dysmorphism (e.g. sloping forehead, high and broad nasal bridge) and variable brain malformations, including simplified gyration, pachygyria, polymicrogyria, reduced sulcation, dysgenesis of corpus callosum and deformed ventricles. Renal anomalies, bilateral hearing loss, multiple joint contractures, severe failure to thrive and a sacral lesion cephalad to the gluteal crease have also been reported.</Contents>
+              <Contents>A rare, genetic, neurodevelopmental disorder with primordial microcephaly characterized by primary microcephaly, moderate to severe intellectual disability, and global developmental delay. Variable brain malformations are common ranging from simplified gyration, to cortical malformations such as pachygyria, polymicrogyria, reduced sulcation and midline defects. Craniofacial dysmorphism (e.g. sloping forehead, high and broad nasal bridge) are related to the primary microcephaly. Short stature is frequently observed, and may be severe.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -390691,7 +391002,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="124211">
+        <ExternalReference id="188413">
           <Source>ICD-10</Source>
           <Reference>D61.0</Reference>
           <DisorderMappingRelation id="21534">
@@ -390700,8 +391011,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="90346">
@@ -390763,7 +391074,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="124213">
+        <ExternalReference id="188414">
           <Source>ICD-10</Source>
           <Reference>H47.2</Reference>
           <DisorderMappingRelation id="21534">
@@ -390772,8 +391083,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -394196,7 +394507,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="124267">
+        <ExternalReference id="188517">
           <Source>ICD-10</Source>
           <Reference>E77.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -394205,8 +394516,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="91732">
@@ -394230,7 +394541,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare, genetic, inborn error of metabolism disorder characterized by global developmental delay, hypotonia, choreoathetosis, hypo-/alacrimia, and liver dysfunction which manifests with elevated liver transanimases and hepatocyte cytoplasmic storage material or vacuolization on liver biposy. Additional features reported include acquired microcephaly, hypo-/areflexia, seizures, peripheral neuropathy, intellectual and language/speech disability, additional ocular anomalies and EEG and brain imaging abnomalities.</Contents>
+              <Contents>A rare, genetic, inborn error of metabolism disorder characterized by global developmental delay, hypotonia, choreoathetosis, hypo-/alacrimia, and liver dysfunction which manifests with elevated liver transanimases and hepatocyte cytoplasmic storage material or vacuolization on liver biopsy. Additional features reported include acquired microcephaly, hypo-/areflexia, seizures, peripheral neuropathy, intellectual and language/speech disability, additional ocular anomalies and EEG and brain imaging abnomalities.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -394239,7 +394550,7 @@
     <Disorder id="22920">
       <OrphaCode>404443</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=404443</ExpertLink>
-      <Name lang="en">Tall stature-intellectual disability-facial dysmorphism syndrome</Name>
+      <Name lang="en">Tatton-Brown-Rahman syndrome</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -394603,6 +394914,19 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="7">
+        <ExternalReference id="187792">
+          <Source>ICD-10</Source>
+          <Reference>C43.9</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="140733">
           <Source>UMLS</Source>
           <Reference>C0205747</Reference>
@@ -394669,19 +394993,6 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="124282">
-          <Source>ICD-10</Source>
-          <Reference>D22.9</Reference>
-          <DisorderMappingRelation id="21576">
-            <Name lang="en">ND (not yet decided/unable to decide)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="1">
         <DisorderDisorderAssociation>
@@ -400311,17 +400622,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="124118">
+        <ExternalReference id="188412">
           <Source>ICD-10</Source>
-          <Reference>D84.8</Reference>
+          <Reference>D81.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -406886,9 +407197,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="124489">
+        <ExternalReference id="187912">
           <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -408434,7 +408745,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124128" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161941" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare obstetric disease characterized by inadequate blood flow to the placenta during pregnancy, resulting in a decrease in trans-placental transfer of oxygen and nutrients to the fetus, potentially leading to fetal growth retardation, distress, or death. Maternal risk factors include preeclampsia, gestational diabetes, and smoking, among others.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23377">
@@ -411018,7 +411339,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124112" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161804" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare disorder of porphyrin and heme metabolism characterized by infantile or childhood onset of severe cutaneous photosensitivity in affected males, presenting as tingling, burning, and itching within minutes of light exposure, often accompanied by swelling and redness of the skin. Pain may persist for hours or days after the initial reaction. Some patients show hepatic involvement and gallstone formation. Laboratory examination reveals increased levels of zinc- and metal-free protoporphyrin. The phenotype in heterozygous females ranges from asymptomatic to severe.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8026">
@@ -411805,19 +412136,6 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="15">
-        <ExternalReference id="112726">
-          <Source>ICD-10</Source>
-          <Reference>E11.9</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
         <ExternalReference id="7877">
           <Source>OMIM</Source>
           <Reference>125850</Reference>
@@ -411829,6 +412147,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187797">
+          <Source>ICD-10</Source>
+          <Reference>E13</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="7878">
           <Source>OMIM</Source>
           <Reference>125851</Reference>
@@ -414214,9 +414545,9 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="124561">
+        <ExternalReference id="188399">
           <Source>ICD-10</Source>
-          <Reference>D61.0</Reference>
+          <Reference>D89.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -420754,7 +421085,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="124383">
+        <ExternalReference id="188518">
           <Source>ICD-10</Source>
           <Reference>G60.0</Reference>
           <DisorderMappingRelation id="21534">
@@ -420763,8 +421094,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -421374,11 +421705,11 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179214">
+        <ExternalReference id="188520">
           <Source>ICD-10</Source>
-          <Reference>C22.0</Reference>
-          <DisorderMappingRelation id="21576">
-            <Name lang="en">ND (not yet decided/unable to decide)</Name>
+          <Reference>C22.1</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
@@ -421387,17 +421718,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="124441">
+        <ExternalReference id="188519">
           <Source>ICD-10</Source>
-          <Reference>C22.1</Reference>
-          <DisorderMappingRelation id="21576">
-            <Name lang="en">ND (not yet decided/unable to decide)</Name>
+          <Reference>C22.0</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -423098,13 +423429,10 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="7">
+      <SynonymList count="4">
         <Synonym lang="en">Arthritis urethritica</Synonym>
         <Synonym lang="en">Fiessinger-Leroy disease</Synonym>
-        <Synonym lang="en">Fiessinger-Leroy-Reiter syndrome</Synonym>
         <Synonym lang="en">Polyarthritis enterica</Synonym>
-        <Synonym lang="en">Reiter disease</Synonym>
-        <Synonym lang="en">Reiter syndrome</Synonym>
         <Synonym lang="en">Venereal arthritis</Synonym>
       </SynonymList>
       <DisorderType id="21394">
@@ -429411,17 +429739,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179662">
+        <ExternalReference id="188529">
           <Source>ICD-10</Source>
-          <Reference>E75.2</Reference>
+          <Reference>G93.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="151080">
@@ -429638,7 +429966,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A rare genetic neurodegenerative disease characterized by early-onset diffuse brain atrophy, growth failure with postnatal microcephaly, developmental delay, regression, profound intellectual disability, hypotonia, muscle weakness and atrophy, intractable seizures, spasticity, and optic atrophy. Patients are usually immobile and often require mechanical ventilation. Brain imaging shows cerebral and cerebellar atrophy, hypomyelination, and thin corpus callosum.</Contents>
+              <Contents>A rare, severe early-onset neurodegenerative encephalopathy characterized mainly by developmental delay (DD) / developmental regression (DR), epilepsy, cortical atrophy, secondary hypomyelination and thin corpus callosum. Additional features include secondary microcephaly, hypotonia, spasticity, optic atrophy and skeletal anomalies.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -429850,17 +430178,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179663">
+        <ExternalReference id="188530">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>G31.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -429910,17 +430238,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179664">
+        <ExternalReference id="188531">
           <Source>ICD-10</Source>
-          <Reference>G60.8</Reference>
+          <Reference>E88.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -430394,7 +430722,11 @@
       <OrphaCode>494348</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=494348</ExpertLink>
       <Name lang="en">Early-onset familial noncirrhotic portal hypertension</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -430421,18 +430753,25 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="29788">
+            <OrphaCode>596937</OrphaCode>
+            <Name lang="en">Portosinusoidal vascular disease</Name>
+          </TargetDisorder>
+          <RootDisorder id="25668" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="120063" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="154361" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>A rare genetic hepatic disease characterized by early onset of portal hypertension in the absence of liver cirrhosis, other causes of liver disease, or splanchnic venous thrombosis at some point in the disease process. Consequences include occurrence of hepatosplenomegaly with thrombocytopenia and esophageal varices with potential bleeding. Liver enzymes may be elevated, while liver function is usually normal, and the overall clinical phenotype typically benign.</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Portosinusoidal vascular disease</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -432344,17 +432683,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="2">
-        <ExternalReference id="179669">
+        <ExternalReference id="188536">
           <Source>ICD-10</Source>
-          <Reference>E85.0</Reference>
+          <Reference>D89.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
         <ExternalReference id="155778">
@@ -437602,17 +437941,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179665">
+        <ExternalReference id="188532">
           <Source>ICD-10</Source>
-          <Reference>G11.0</Reference>
+          <Reference>G11.2</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -439548,17 +439887,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179666">
+        <ExternalReference id="188533">
           <Source>ICD-10</Source>
-          <Reference>E85.0</Reference>
+          <Reference>N94.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -440664,7 +441003,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease is described under  Congenital pulmonary valvar stenosis</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8607">
@@ -440751,17 +441097,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179668">
+        <ExternalReference id="188535">
           <Source>ICD-10</Source>
-          <Reference>G60.8</Reference>
+          <Reference>H46</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -441885,17 +442231,17 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179667">
+        <ExternalReference id="188534">
           <Source>ICD-10</Source>
-          <Reference>Q68.8</Reference>
+          <Reference>Q74.3</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -442670,9 +443016,10 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="4">
+      <SynonymList count="5">
         <Synonym lang="en">Fistulous vegetative verrucous hydradenoma</Synonym>
         <Synonym lang="en">Naevus syringocystadenomatosus papilliferus</Synonym>
+        <Synonym lang="en">Papillary syringocystadenoma</Synonym>
         <Synonym lang="en">SCAP</Synonym>
         <Synonym lang="en">Syringadenoma papilliferum</Synonym>
       </SynonymList>
@@ -443176,7 +443523,20 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="4">
+      <ExternalReferenceList count="5">
+        <ExternalReference id="188403">
+          <Source>ICD-10</Source>
+          <Reference>D23.9</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="113094">
           <Source>MeSH</Source>
           <Reference>D058249</Reference>
@@ -447816,7 +448176,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179660">
+        <ExternalReference id="188527">
           <Source>ICD-10</Source>
           <Reference>D84.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -447825,8 +448185,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -448021,7 +448381,7 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="179661">
+        <ExternalReference id="188528">
           <Source>ICD-10</Source>
           <Reference>G60.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -448030,8 +448390,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -451378,7 +451738,7 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="179659">
+        <ExternalReference id="188526">
           <Source>ICD-10</Source>
           <Reference>G60.8</Reference>
           <DisorderMappingRelation id="21534">
@@ -451387,8 +451747,8 @@
           <DisorderMappingICDRelation id="21604">
             <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
           </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21618">
-            <Name lang="en">Not yet validated</Name>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
@@ -457284,7 +457644,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>CEDNIK syndrome is a neurocutaneaous syndrome characterized by severe developmental abnormalities of the nervous system and aberrant differentiation of the epidermis.</Contents>
+              <Contents>A rare, genetic, neurocutaneous disease characterized by severe developmental abnormalities of the nervous system and aberrant differentiation of the epidermis. Patients present with a unique constellation of clinical signs described with the acronym CEDNIK: CErebral Dysgenesis, Neuropathy, Ichthyosis, and palmoplantar Keratoderma.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -458454,7 +458814,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124113" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161805" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare vaginal malformation characterized by congenital uterovaginal outflow tract obstruction due to failure of the urogenital sinus to form the caudal aspect of the vagina, which is then replaced by fibrous tissue. The malformation may occur as an isolated developmental defect or in association with other anomalies, such as cervical agenesis, imperforate hymen, and bicornuate bicervical uterus. Presenting signs and symptoms include primary amenorrhea, cyclic pelvic pain, abdominal pain, dyspareunia, pelvic mass, menstrual disorder, and periodic fever.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10870">
@@ -461146,11 +461516,11 @@
       <SynonymList count="1">
         <Synonym lang="en">Obliterative portal venopathy</Synonym>
       </SynonymList>
-      <DisorderType id="21394">
-        <Name lang="en">Disease</Name>
+      <DisorderType id="21457">
+        <Name lang="en">Histopathological subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="en">Disorder</Name>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
         <ExternalReference id="114567">
@@ -464282,7 +464652,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Prion diseases are a group of rare transmissible disorders characterized by progressive debilitating neurological manifestations due to spongiform changes with an invariably fatal course. The disorders all involve accumulation of an abnormal prion protein in the central nervous system with no specific immunological response. Sporadic Creutzfeldt-Jakob disease (CJD; see this term) is the most frequent form accounting for about 85% of prion disease cases. The other forms of prion disease are genetic (5-15%) and include inherited CJD, fatal familial insomnia (FFI), and Familial Alzheimer-like prion disease (see these terms). Acquired forms (&lt; 5%) include iatrogenic CJD and variant CJD (vCDJ).</Contents>
+              <Contents>A group of rare neurodegenerative diseases characterized by the accumulation of prions, abnormal variants of the cellular prion protein, primarily in brain tissue of affected individuals, as well as massive, rapid neuronal death, and an invariably fatal course. Human prion diseases most often occur sporadically but may also be of genetic origin or infectiously acquired. Irrespective of etiology, they are transmissible to other individuals.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -465420,9 +465790,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="114328">
+        <ExternalReference id="187905">
           <Source>ICD-10</Source>
-          <Reference>N00.5</Reference>
+          <Reference>N03.5</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -468220,7 +468590,20 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
+      <ExternalReferenceList count="2">
+        <ExternalReference id="187914">
+          <Source>ICD-10</Source>
+          <Reference>E88.8</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="179596">
           <Source>OMIM</Source>
           <Reference>618397</Reference>
@@ -468529,7 +468912,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124127" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161940" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare intoxication characterized by acute renal tubular toxicity due to crystallization of methotrexate in the renal tubular lumen (which in turn leads to impaired methotrexate clearance and further deterioration of renal function and exacerbation of non-renal adverse events), myelosuppression with pancytopenia, gastrointestinal mucositis, maculopapular skin rash, chemical conjunctivitis, hepatotoxicity (reversible chemical hepatitis and hyperbilirubinemia), pulmonary toxicity, and, in severe cases, multiorgan failure. Central nervous system involvement, including headaches, seizures, and stroke-like symptoms, may also be observed.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11216">
@@ -474326,12 +474719,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="124350" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="162412" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy with gluteofemoral fat loss, as well as increased fat accumulation in the face and trunk and visceral adiposity. Additional manifestations include diabetes mellitus, atherogenic dyslipidemia, eyelid xanthelasmas, arterial hypertension, cardiovascular disease, hepatic steatosis, acanthosis nigricans on axillae and neck, hirsutism, and muscular hypertrophy of the lower limbs.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This disease is described under  Familial partial lipodystrophy</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -474771,12 +475167,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="124351" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="162413" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy and severe insulin resistance in the liver and peripheral tissues, hyperinsulinemia, and diabetes mellitus. Acanthosis nigricans and hypertension have been reported in association.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This disease is described under  Familial partial lipodystrophy</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -476035,7 +476434,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Ehlers-Danlos syndromes (EDS) form a heterogeneous group of hereditary connective tissue diseases characterized by joint hyperlaxity, cutaneous hyperelasticity and tissue fragility.</Contents>
+              <Contents>A rare type of Ehlers-Danlos syndrome characterized by childhood or adolescence onset of severe, intractable periodontitis, lack of attached gingiva, and presence of pretibial plaques. Additional manifestations are easy bruising, hypermobility mainly of the distal joints, skin hyperextensibility and fragility, abnormal scarring, recurrent infections, hernias, marfanoid facial features, acrogeria, and prominent vasculature.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -476155,7 +476554,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11083" cycle="true"/>
+          <RootDisorder id="20904">
+            <OrphaCode>294049</OrphaCode>
+            <Name lang="en">Reunion Island Larsen-like syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="24348" lang="en">
@@ -476856,7 +477265,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>6q terminal deletion syndrome is marked by a characteristic facial dysmorphism, short neck and psychomotor retardation, generally associated with a range of non-specific malformations.</Contents>
+              <Contents>A rare partial deletion of the long arm of chromosome 6 characterized by a variable clinical phenotype that includes a characteristic craniofacial dysmorphism (including microcephaly, broad nose with prominent nasal root and bulbous nasal tip, large ears that may be malformed and low-set, characteristic downturned mouth, and short neck), global development delay, intellectual disability, and variable, non-specific, congenital malformations. Muscular hypotonia, seizures, retinal anomalies, and variable brain abnormalities have been reported in association.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -479218,19 +479627,6 @@
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="5">
-        <ExternalReference id="114892">
-          <Source>ICD-10</Source>
-          <Reference>D75.2</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
         <ExternalReference id="61348">
           <Source>OMIM</Source>
           <Reference>187950</Reference>
@@ -479275,6 +479671,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="188404">
+          <Source>ICD-10</Source>
+          <Reference>D68.8</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -480412,7 +480821,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Tubular renal disease-cardiomyopathy syndrome is characterised by hypokalaemic metabolic alkalosis secondary to a tubulopathy, hypomagnesaemia with hypermagnesuria, severe hypercalciuria and dilated cardiomyopathy.</Contents>
+              <Contents>A rare renal disease characterised by hypokalaemic metabolic alkalosis secondary to a tubulopathy, hypomagnesaemia with hypermagnesuria, severe hypercalciuria and dilated cardiomyopathy.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -480658,7 +481067,11 @@
       <OrphaCode>73220</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=73220</ExpertLink>
       <Name lang="en">X-linked intellectual disability-hypotonic face syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -480666,14 +481079,14 @@
       </DisorderFlagList>
       <SynonymList count="0">
       </SynonymList>
-      <DisorderType id="21436">
-        <Name lang="en">Clinical group</Name>
+      <DisorderType id="21401">
+        <Name lang="en">Malformation syndrome</Name>
       </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="en">Group of disorders</Name>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="10653">
+        <ExternalReference id="188181">
           <Source>OMIM</Source>
           <Reference>309580</Reference>
           <DisorderMappingRelation id="21527">
@@ -480685,18 +481098,25 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900">
+            <OrphaCode>847</OrphaCode>
+            <Name lang="en">Alpha-thalassemia-X-linked intellectual disability syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="11034" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="32090" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="117274" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>Mental retardation-hypotonic facies covers a group of X-linked syndromes characterized by severe intellectual deficit and facial dysmorphism, with variable other features.</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Alpha-thalassemia-X-linked intellectual disability syndrome</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -483382,20 +483802,7 @@
       <DisorderGroup id="36540">
         <Name lang="en">Group of disorders</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="113752">
-          <Source>ICD-10</Source>
-          <Reference>E88.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="1">
         <DisorderDisorderAssociation>
@@ -490002,7 +490409,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>A subtype of autosomal recessive limb-girdle muscular dystrophy that presents a highly variable age of onset and phenotypic spectrum typically characterized by slowly progressive proximal weakness of the pelvic and shoulder girdle musculature (predominantly affecting the lower limbs), frequently associated with waddling gait, scapular winging, calf and tongue hypertrophy, exercise-induced myalgia, and myoglobinuria and/or elevated creatine kinase serum levels. Abdominal muscle weakness, cardiomyopathy, respiratory muscle involvement and various brain abnormalities have also been reported.</Contents>
+              <Contents>A form of autosomal recessive limb-girdle muscular dystrophy that presents a highly variable age of onset and phenotypic spectrum typically characterized by slowly progressive proximal weakness of the pelvic and shoulder girdle musculature (predominantly affecting the lower limbs), frequently associated with waddling gait, scapular winging, calf and tongue hypertrophy, exercise-induced myalgia, abdominal muscle weakness, cardiomyopathy, respiratory muscle involvement, and myoglobinuria and/or elevated creatine kinase serum levels.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -494491,7 +494898,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124107" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161799" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare arthrogryposis syndrome characterized by the association of arthrogryposis multiplex congenita and a severe form of motor neuron disease with loss of anterior horn cells in the spinal cord. Patients present with fetal akinesia deformation sequence with multiple contractures and facial anomalies, such as low-set ears, hypoplastic jaw, and short neck, as well as hypotonia and respiratory insufficiency. Some patients may survive into childhood and show developmental delay, markedly decreased muscle bulk, dystonic and involuntary movements, ataxia, and poor speech.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27954">
@@ -498439,7 +498856,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124125" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161938" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare immune dysregulation disease with immunodeficiency characterized by infantile or childhood onset of a variable phenotype including recurrent/persistent bacterial, fungal, and viral infections with involvement of the skin, lower respiratory tract, and gastrointestinal tract, eczema, allergies, and inflammatory bowel disease, among others. EBV-related smooth muscle tumors have also been reported. Immunophenotyping shows decreased Treg counts, as well as a deficient CD3/CD28 co-stimulation response in CD4+ and CD8+ T-cells.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28038">
@@ -501138,11 +501565,11 @@
       <SynonymList count="1">
         <Synonym lang="en">Non-cirrhotic nodulation</Synonym>
       </SynonymList>
-      <DisorderType id="21394">
-        <Name lang="en">Disease</Name>
+      <DisorderType id="21457">
+        <Name lang="en">Histopathological subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="en">Disorder</Name>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
         <ExternalReference id="114084">
@@ -501749,7 +502176,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124110" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161802" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare genetic syndromic intellectual disability characterized by infantile onset of global developmental delay and profound intellectual disability in association with a heterogeneous spectrum of manifestations, such as features of lower motor neuron disease, hypotonia, spasticity, contractures, seizures, respiratory insufficiency, and optic atrophy, among others. Dysmorphic craniofacial features include microcephaly, tall forehead, bitemporal narrowing, flat nasal bridge, low-set ears, and high-arched palate. Brain imaging may show cerebral and cerebellar atrophy, delayed myelination, and thin corpus callosum.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28081">
@@ -501937,7 +502374,14 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease is described under  Atypical hemolytic uremic syndrome</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10608">
@@ -502152,7 +502596,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124136" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161950" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare congenital myopathy characterized by neonatal onset of severe muscle weakness with selective atrophy/hypotrophy or absence of type II myofibers. Patients present at birth with hypotonia and respiratory failure, as well as mild facial and severe axial and proximal upper and lower limb weakness with areflexia and mild contractures. Eye movements and cardiac function are normal.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10616">
@@ -505350,12 +505804,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="124229" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="162143" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare hepatic disease characterized by recurrence of hepatitis C virus infection after liver transplantation, leading to liver injury with features resembling those observed in the non-transplant graft, and typically developing after three months post-transplantation. The clinical course is highly variable, although patients most commonly develop progressive chronic liver disease with higher viral loads and more rapid fibrosis progression than in the immunocompetent population.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This is a rare condition for which there is a European and/or American orphan designation.</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -506560,12 +507017,15 @@
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
+        <SummaryInformation id="124108" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161800" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare neurologic condition characterized by brain damage caused by an external mechanical force, with a Glasgow Coma Scale score of 9 to 12 in moderate traumatic brain injury (TBI), or 3 to 8 in severe TBI, respectively. TBI can be closed (with the dura mater remaining intact) or open (with penetration of the dura mater) and may lead to focal damage, such as cerebral contusion and hemorrhage, as well as diffuse axonal injury and secondary damage due to increased intracranial pressure. Signs and symptoms are highly variable, depending on the nature, severity, localization, and extent of the trauma.</Contents>
+            </TextSection>
           </TextSectionList>
-          <TextAuto>
-            <Info lang="en">This is a rare condition for which there is a European and/or American orphan designation.</Info>
-          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -507431,7 +507891,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Inflammatory pseudotumor (IPT) of the liver is a rare benign tumor-like lesion.</Contents>
+              <Contents>A rare benign liver tumor characterized by a prominent inflammatory infiltrate and often mimicking a malignant liver neoplasm. The tumor is frequently solitary with a predilection for the right lobe; however, multiple lesions are possible. There are two clinicopathological subtypes: fibrohistiocytic inflammatory pseudotumor of the liver and lymphoplasmacytic inflammatory pseudotumor of the liver. Patients present with non-specific clinical symptoms such as abdominal pain or discomfort, fever, and weight loss. The condition may be associated with other chronic inflammatory or autoimmune diseases.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -515034,7 +515494,7 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="45">
+      <ExternalReferenceList count="49">
         <ExternalReference id="100773">
           <Source>OMIM</Source>
           <Reference>616887</Reference>
@@ -515112,6 +515572,58 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187930">
+          <Source>ICD-10</Source>
+          <Reference>F70</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187933">
+          <Source>ICD-10</Source>
+          <Reference>F73</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187932">
+          <Source>ICD-10</Source>
+          <Reference>F72</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187931">
+          <Source>ICD-10</Source>
+          <Reference>F71</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="103935">
           <Source>OMIM</Source>
           <Reference>617028</Reference>
@@ -519516,7 +520028,20 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
+      <ExternalReferenceList count="2">
+        <ExternalReference id="187916">
+          <Source>ICD-10</Source>
+          <Reference>E88.8</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="160602">
           <Source>OMIM</Source>
           <Reference>617021</Reference>
@@ -519634,7 +520159,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="11">
+      <ExternalReferenceList count="12">
         <ExternalReference id="184333">
           <Source>OMIM</Source>
           <Reference>618914</Reference>
@@ -519745,6 +520270,17 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187973">
+          <Source>OMIM</Source>
+          <Reference>309590</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation/>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
         <ExternalReference id="171470">
           <Source>OMIM</Source>
           <Reference>617755</Reference>
@@ -519757,7 +520293,47 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="4">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491" cycle="true"/>
+          <RootDisorder id="2746">
+            <OrphaCode>3056</OrphaCode>
+            <Name lang="en">X-linked intellectual disability, Brooks type</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491" cycle="true"/>
+          <RootDisorder id="11698">
+            <OrphaCode>85328</OrphaCode>
+            <Name lang="en">X-linked intellectual disability, Turner type</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491" cycle="true"/>
+          <RootDisorder id="12530">
+            <OrphaCode>93972</OrphaCode>
+            <Name lang="en">Juberg-Marsidi syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491" cycle="true"/>
+          <RootDisorder id="12533">
+            <OrphaCode>93975</OrphaCode>
+            <Name lang="en">OBSOLETE: Renier-Gabreels-Jasper syndrome</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="123580" lang="en">
@@ -522103,9 +522679,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="117149">
+        <ExternalReference id="188402">
           <Source>ICD-10</Source>
-          <Reference>E11.2</Reference>
+          <Reference>N11.8</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -549709,7 +550285,11 @@
       <OrphaCode>85328</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=85328</ExpertLink>
       <Name lang="en">X-linked intellectual disability, Turner type</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -549723,7 +550303,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="4">
+      <ExternalReferenceList count="3">
         <ExternalReference id="171191">
           <Source>OMIM</Source>
           <Reference>309590</Reference>
@@ -549746,9 +550326,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="43055">
-          <Source>OMIM</Source>
-          <Reference>300706</Reference>
+        <ExternalReference id="187972">
+          <Source>UMLS</Source>
+          <Reference>C4305074</Reference>
           <DisorderMappingRelation id="21527">
             <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
@@ -549757,32 +550337,26 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="116186">
-          <Source>ICD-10</Source>
-          <Reference>Q87.8</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491">
+            <OrphaCode>528084</OrphaCode>
+            <Name lang="en">Non-specific syndromic intellectual disability</Name>
+          </TargetDisorder>
+          <RootDisorder id="11698" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="45090" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="115821" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>X-linked intellectual disability, Turner type is characterised by moderate to severe intellectual deficit in boys and moderate intellectual deficit in girls. It has been described in 14 members from four generations of one family. Macrocephaly was reported and holoprosencephaly may also be present (two family members). The mode of transmission is X-linked semi-dominant.</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Non-specific syndromic intellectual disability</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -558011,9 +558585,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="115849">
+        <ExternalReference id="187796">
           <Source>ICD-10</Source>
-          <Reference>M89.0</Reference>
+          <Reference>G90.6</Reference>
           <DisorderMappingRelation id="21541">
             <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
@@ -558046,9 +558620,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="115848">
+        <ExternalReference id="187795">
           <Source>ICD-10</Source>
-          <Reference>G56.4</Reference>
+          <Reference>G90.5</Reference>
           <DisorderMappingRelation id="21541">
             <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
@@ -559834,7 +560408,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Collagen type III glomerulopathy is a rare glomerular disease characterized by abnormal accumulation of type III collagen within the mesangium and subendothelial space of the glomerulus. Clinically it usually manifests with proteinuria (often in the nephrotic range), microscopic hematuria, peripheral edema and/or hypertension. In some cases, progression to end-stage renal failure is observed.</Contents>
+              <Contents>A rare non-immune-mediated glomerular disease characterized by abnormal accumulation of type III collagen within the mesangium and subendothelial space of the glomerulus. Clinically it usually manifests with proteinuria (often in the nephrotic range), microscopic hematuria, peripheral edema and/or hypertension. Progression to end-stage kidney failure is possible.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -567776,11 +568350,11 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="118133">
+        <ExternalReference id="187901">
           <Source>ICD-10</Source>
           <Reference>M92.2</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
           <DisorderMappingICDRelation id="21590">
             <Name lang="en">Inclusion term (The ORPHA code is included under a ICD10 category and has not its own code)</Name>
@@ -567789,14 +568363,14 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="118134">
+        <ExternalReference id="187900">
           <Source>ICD-10</Source>
-          <Reference>M93.2</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <Reference>M93.1</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
           </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
           </DisorderMappingICDRelation>
           <DisorderMappingValidationStatus id="21611">
             <Name lang="en">Validated</Name>
@@ -571676,7 +572250,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12853">
@@ -574133,7 +574714,7 @@
     <Disorder id="12657">
       <OrphaCode>95702</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=95702</ExpertLink>
-      <Name lang="en">X-linked adrenal hypoplasia congenita due to a NR0B1 point mutation</Name>
+      <Name lang="en">X-linked adrenal hypoplasia congenita</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -574141,8 +574722,8 @@
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="2">
-        <Synonym lang="en">X-linked AHC due to a NR0B1 point mutation</Synonym>
-        <Synonym lang="en">X-linked congenital adrenal hypoplasia due to a NR0B1 point mutation</Synonym>
+        <Synonym lang="en">X-linked AHC</Synonym>
+        <Synonym lang="en">X-linked congenital adrenal hypoplasia</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="en">Disease</Name>
@@ -582901,6 +583482,31 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29860">
+      <OrphaCode>597623</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597623</ExpertLink>
+      <Name lang="en">IRF2BPL- related regressive neurodevelopmental disorder-dystonia-seizures syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12389">
       <OrphaCode>93547</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93547</ExpertLink>
@@ -582971,6 +583577,58 @@
       <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29862">
+      <OrphaCode>597733</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597733</ExpertLink>
+      <Name lang="en">Oculocutaneous albinism type 8</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">OCA8</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29863">
+      <OrphaCode>597738</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597738</ExpertLink>
+      <Name lang="en">Luscan-Lumish syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">SETD2-related overgrowth syndrome</Synonym>
+      </SynonymList>
+      <DisorderType id="21401">
+        <Name lang="en">Malformation syndrome</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12390">
       <OrphaCode>93548</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93548</ExpertLink>
@@ -583075,6 +583733,31 @@
       <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29868">
+      <OrphaCode>597887</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597887</ExpertLink>
+      <Name lang="en">ALPI-related inflammatory bowel disease</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12397">
       <OrphaCode>93555</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93555</ExpertLink>
@@ -583271,6 +583954,31 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29864">
+      <OrphaCode>597743</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597743</ExpertLink>
+      <Name lang="en">SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21401">
+        <Name lang="en">Malformation syndrome</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12393">
       <OrphaCode>93551</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93551</ExpertLink>
@@ -583323,6 +584031,31 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29865">
+      <OrphaCode>597746</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597746</ExpertLink>
+      <Name lang="en">Blepharophimosis-intellectual disability syndrome, SBBYS type/genitopatellar overlap syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21401">
+        <Name lang="en">Malformation syndrome</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12392">
       <OrphaCode>93550</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93550</ExpertLink>
@@ -583365,6 +584098,39 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29866">
+      <OrphaCode>597749</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597749</ExpertLink>
+      <Name lang="en">KAT6B-related multiple congenital anomalies syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">KAT6B-related disorders</Synonym>
+      </SynonymList>
+      <DisorderType id="21436">
+        <Name lang="en">Clinical group</Name>
+      </DisorderType>
+      <DisorderGroup id="36540">
+        <Name lang="en">Group of disorders</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.</Info>
+          </TextAuto>
+        </SummaryInformation>
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12394">
       <OrphaCode>93552</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93552</ExpertLink>
@@ -583453,6 +584219,31 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29867">
+      <OrphaCode>597874</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597874</ExpertLink>
+      <Name lang="en">MTHFS-related developmental delay-microcephaly-short stature- epilepsy syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12404">
       <OrphaCode>93562</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93562</ExpertLink>
@@ -583773,9 +584564,9 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="4">
-        <ExternalReference id="130195">
+        <ExternalReference id="187902">
           <Source>ICD-10</Source>
-          <Reference>N04.6</Reference>
+          <Reference>N03.6</Reference>
           <DisorderMappingRelation id="21527">
             <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
@@ -584138,6 +584929,32 @@
       <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29831">
+      <OrphaCode>597201</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=597201</ExpertLink>
+      <Name lang="en">TRIM22-related inflammatory bowel disease</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">TRIM22-related IBD</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12358">
       <OrphaCode>93447</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93447</ExpertLink>
@@ -587890,7 +588707,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Brachydactyly type A1 (BDA1) is a congenital malformation characterized by apparent shortness (or absence) of the middle phalanges of all digits, and occasional fusion with the terminal phalanges.</Contents>
+              <Contents>A rare, congenital limb malformation characterized by shortened or underdeveloped middle phalanges of all digits, that are sometimes fused with the terminal phalanges. The proximal phalanges of the thumbs and big toes are also shortened. Short stature in adulthood has been reported in association.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -588181,7 +588998,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Brachydactyly type A2 (BDA2) is a congenital malformation characterized by shortening (hypoplasia or aplasia) of the middle phalanges of the index finger and, sometimes, of the little finger.</Contents>
+              <Contents>A rare, congenital limb malformation characterized by shortening (hypoplasia or aplasia) of the middle phalanges of the index finger and, sometimes, of the fifth finger. On radiographs, the middle phalanx of the index fingers often appear triangular and in severely affected cases, the index finger is curved radially. The lower limb phenotype is generally milder.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -589395,11 +590212,11 @@
     <Disorder id="12533">
       <OrphaCode>93975</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93975</ExpertLink>
-      <Name lang="en">Renier-Gabreels-Jasper syndrome</Name>
+      <Name lang="en">OBSOLETE: Renier-Gabreels-Jasper syndrome</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="0">
@@ -589412,26 +590229,30 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491">
+            <OrphaCode>528084</OrphaCode>
+            <Name lang="en">Non-specific syndromic intellectual disability</Name>
+          </TargetDisorder>
+          <RootDisorder id="12533" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="en">Referred to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="44084" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="110606" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>An X-linked mental retardation (XLMR) syndrome belonging to the group of conditions characterised by the association of intellectual deficit with hypotonic facies (Mental retardation, X-linked-hypotonic facies).</Contents>
-            </TextSection>
-          </TextSectionList>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12532">
       <OrphaCode>93974</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93974</ExpertLink>
       <Name lang="en">Smith-Fineman-Myers syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -589445,7 +590266,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="2">
+      <ExternalReferenceList count="1">
         <ExternalReference id="139722">
           <Source>UMLS</Source>
           <Reference>C0796159</Reference>
@@ -589457,30 +590278,26 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="38390">
-          <Source>OMIM</Source>
-          <Reference>309580</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900">
+            <OrphaCode>847</OrphaCode>
+            <Name lang="en">Alpha-thalassemia-X-linked intellectual disability syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="12532" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="44078" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="110590" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>An X-linked mental retardation (XLMR) syndrome belonging to the group of conditions characterised by the association of intellectual deficit with hypotonic facies (Mental retardation, X-linked-hypotonic facies).</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Alpha-thalassemia-X-linked intellectual disability syndrome</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -589593,7 +590410,11 @@
       <OrphaCode>93971</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93971</ExpertLink>
       <Name lang="en">Chudley-Lowry-Hoar syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -589608,31 +590429,27 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="39697">
-          <Source>OMIM</Source>
-          <Reference>309580</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900">
+            <OrphaCode>847</OrphaCode>
+            <Name lang="en">Alpha-thalassemia-X-linked intellectual disability syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="12529" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="44060" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="110130" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>An X-linked mental retardation (XLMR) syndrome belonging to the group of conditions characterised by the association of intellectual deficit with hypotonic facies (Mental retardation-hypotonic facies).</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Alpha-thalassemia-X-linked intellectual disability syndrome</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -589640,7 +590457,11 @@
       <OrphaCode>93970</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93970</ExpertLink>
       <Name lang="en">Holmes-Gang syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -589654,44 +590475,27 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="2">
-        <ExternalReference id="117550">
-          <Source>ICD-10</Source>
-          <Reference>Q87.0</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="39699">
-          <Source>OMIM</Source>
-          <Reference>309580</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900">
+            <OrphaCode>847</OrphaCode>
+            <Name lang="en">Alpha-thalassemia-X-linked intellectual disability syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="12528" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="44054" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="110570" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>An X-linked mental retardation (XLMR) syndrome belonging to the group of conditions characterised by the association of intellectual deficit with hypotonic facies (Mental retardation, X-linked-hypotonic facies).</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Alpha-thalassemia-X-linked intellectual disability syndrome</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -589699,7 +590503,11 @@
       <OrphaCode>93973</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93973</ExpertLink>
       <Name lang="en">Carpenter-Waziri syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -589713,31 +590521,27 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="36074">
-          <Source>OMIM</Source>
-          <Reference>309580</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="900">
+            <OrphaCode>847</OrphaCode>
+            <Name lang="en">Alpha-thalassemia-X-linked intellectual disability syndrome</Name>
+          </TargetDisorder>
+          <RootDisorder id="12531" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="44072" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="110578" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>An X-linked mental retardation (XLMR) syndrome belonging to the group of conditions characterised by the association of intellectual deficit with hypotonic facies (Mental retardation, X-linked-hypotonic facies).</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Alpha-thalassemia-X-linked intellectual disability syndrome</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -589745,7 +590549,11 @@
       <OrphaCode>93972</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93972</ExpertLink>
       <Name lang="en">Juberg-Marsidi syndrome</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -589759,7 +590567,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
+      <ExternalReferenceList count="2">
         <ExternalReference id="117551">
           <Source>MeSH</Source>
           <Reference>C537457</Reference>
@@ -589782,30 +590590,26 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="39701">
-          <Source>OMIM</Source>
-          <Reference>309580</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27491">
+            <OrphaCode>528084</OrphaCode>
+            <Name lang="en">Non-specific syndromic intellectual disability</Name>
+          </TargetDisorder>
+          <RootDisorder id="12530" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
-        <SummaryInformation id="44066" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="116554" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="en">Definition</Name>
-              </TextSectionType>
-              <Contents>An X-linked mental retardation (XLMR) syndrome belonging to the group of conditions characterised by the association of intellectual deficit with hypotonic facies (Mental retardation, X-linked-hypotonic facies).</Contents>
-            </TextSection>
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
           </TextSectionList>
+          <TextAuto>
+            <Info lang="en">This disease has been moved to  Non-specific syndromic intellectual disability</Info>
+          </TextAuto>
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
@@ -590752,7 +591556,7 @@
     <Disorder id="29725">
       <OrphaCode>595133</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=595133</ExpertLink>
-      <Name lang="en">Perivascular Epithelioid Cell Neoplasm</Name>
+      <Name lang="en">Perivascular epithelioid cell neoplasm</Name>
       <DisorderFlagList count="1">
         <DisorderFlag id="475">
           <Value>1</Value>
@@ -591979,7 +592783,7 @@
               <TextSectionType id="16907">
                 <Name lang="en">Definition</Name>
               </TextSectionType>
-              <Contents>Juvenile dermatomyositis (JDM) is the early-onset form of dermatomyositis (DM, see this term), a systemic, autoimmune inflammatory muscle disorder, characterized by proximal muscle weakness, evocative skin lesion, and systemic manifestations.</Contents>
+              <Contents>An early-onset form of dermatomyositis (DM), a systemic, autoimmune inflammatory muscle disorder with vasculopathy, characterized by proximal and symmetrical muscle weakness, evocative skin lesions, and systemic manifestations. Vasculopathy occurs in the skin, muscle (mainly in the perifascicular area), and sometimes in the intestinal tissue.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -593165,6 +593969,32 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29784">
+      <OrphaCode>596759</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596759</ExpertLink>
+      <Name lang="en">Combined immunodeficiency due to Rela haploinsufficiency</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">CID due to Rela haploinsufficiency</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12441">
       <OrphaCode>93608</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93608</ExpertLink>
@@ -593398,6 +594228,42 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29788">
+      <OrphaCode>596937</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596937</ExpertLink>
+      <Name lang="en">Portosinusoidal vascular disease</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">PSVD</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="29788" cycle="true"/>
+          <RootDisorder id="25668">
+            <OrphaCode>494348</OrphaCode>
+            <Name lang="en">Early-onset familial noncirrhotic portal hypertension</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="en">Moved to</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12445">
       <OrphaCode>93612</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93612</ExpertLink>
@@ -593465,6 +594331,32 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29789">
+      <OrphaCode>596941</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596941</ExpertLink>
+      <Name lang="en">Incomplete septal cirrhosis</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">Incomplete septal fibrosis</Synonym>
+      </SynonymList>
+      <DisorderType id="21457">
+        <Name lang="en">Histopathological subtype</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12444">
       <OrphaCode>93611</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93611</ExpertLink>
@@ -593912,6 +594804,32 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29783">
+      <OrphaCode>596753</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=596753</ExpertLink>
+      <Name lang="en">VEXAS syndrome</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">Vacuole, E1 enzyme, X-linked, autoinflammatory, somatic</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="en">Disease</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="en">Disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="12438">
       <OrphaCode>93605</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=93605</ExpertLink>
@@ -596112,7 +597030,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124352" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="162414" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare congenital anomaly of superior vena cava characterized by a persistent left superior vena cava that drains into the left atrium through a direct connection to its roof, creating a right-to-left shunt. Patients are at risk of developing chronic hypoxia, decreased exercise tolerance, cyanosis, embolic cerebrovascular events, and heart failure.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="14129">
@@ -597309,8 +598237,9 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
         <Synonym lang="en">NMOSD without anti-MOG antibodies and without anti-AQP4 antibodies</Synonym>
+        <Synonym lang="en">Neuromyelitis optica spectrum disorder without anti-Myelin oligodendrocyte glycoprotein and without anti-Aquaporin-4 antibodies</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -597409,7 +598338,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Isolated optic neuritis without anti-myelin oligodendrocyte glycoprotein antibodies</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -597533,7 +598463,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">Acute disseminated encephalomyelitis without anti-myelin oligodendrocyte glycoprotein antibodies</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -628217,8 +629148,9 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
         <Synonym lang="en">BPES type 2</Synonym>
+        <Synonym lang="en">Blepharophimosis-ptosis-epicanthus inversus syndrome without premature ovarian failure</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -628756,7 +629688,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
+      <ExternalReferenceList count="2">
         <ExternalReference id="180566">
           <Source>OMIM</Source>
           <Reference>617710</Reference>
@@ -628768,6 +629700,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187920">
+          <Source>ICD-10</Source>
+          <Reference>E88.8</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -629350,8 +630295,9 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="1">
+      <SynonymList count="2">
         <Synonym lang="en">BPES type 1</Synonym>
+        <Synonym lang="en">Blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian failure</Synonym>
       </SynonymList>
       <DisorderType id="21450">
         <Name lang="en">Clinical subtype</Name>
@@ -629560,7 +630506,7 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
+      <ExternalReferenceList count="2">
         <ExternalReference id="184327">
           <Source>OMIM</Source>
           <Reference>618835</Reference>
@@ -629572,6 +630518,19 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
+        <ExternalReference id="187921">
+          <Source>ICD-10</Source>
+          <Reference>E88.8</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -632447,18 +633406,7 @@
       <DisorderGroup id="36540">
         <Name lang="en">Group of disorders</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="11">
-        <ExternalReference id="139114">
-          <Source>UMLS</Source>
-          <Reference>C0014544</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="en">Validated</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="10">
         <ExternalReference id="119772">
           <Source>ICD-10</Source>
           <Reference>G40.0</Reference>
@@ -634623,7 +635571,59 @@
       <DisorderGroup id="36547">
         <Name lang="en">Disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="0">
+      <ExternalReferenceList count="4">
+        <ExternalReference id="187941">
+          <Source>ICD-10</Source>
+          <Reference>F73</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187939">
+          <Source>ICD-10</Source>
+          <Reference>F71</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187940">
+          <Source>ICD-10</Source>
+          <Reference>F72</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
+        <ExternalReference id="187938">
+          <Source>ICD-10</Source>
+          <Reference>F70</Reference>
+          <DisorderMappingRelation id="21541">
+            <Name lang="en">BTNT (ORPHA code's Broader Term maps to a Narrower Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="en">Validated</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -646212,14 +647212,14 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="119461">
+        <ExternalReference id="187794">
           <Source>ICD-10</Source>
-          <Reference>M89.0</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          <Reference>G90.5</Reference>
+          <DisorderMappingRelation id="21527">
+            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21590">
-            <Name lang="en">Inclusion term (The ORPHA code is included under a ICD10 category and has not its own code)</Name>
+          <DisorderMappingICDRelation id="21583">
+            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
           </DisorderMappingICDRelation>
           <DisorderMappingValidationStatus id="21611">
             <Name lang="en">Validated</Name>
@@ -646321,9 +647321,9 @@
             <Name lang="en">Validated</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="119458">
+        <ExternalReference id="187793">
           <Source>ICD-10</Source>
-          <Reference>G56.4</Reference>
+          <Reference>G90.6</Reference>
           <DisorderMappingRelation id="21527">
             <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
           </DisorderMappingRelation>
@@ -652336,7 +653336,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="124109" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="161801" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="en">Definition</Name>
+              </TextSectionType>
+              <Contents>A rare acute lymphoblastic leukemia characterized by infiltration of bone marrow and peripheral blood by small to medium-sized blast cells typically positive for the B-cell markers CD19, cCD79a, and cCD22. Predilection sites for extramedullary involvement are the central nervous system, lymph nodes, spleen, liver, and testes. Patients present with evidence of bone marrow failure (i. e. thrombocytopenia, anemia, and/or neutropenia) and variable leukocyte count, as well as lymphadenopathy, hepatomegaly, splenomegaly, bone pain, and arthralgias.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="14432">
